Astria Therapeutics, Inc. (ATXS) Misses Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Join SI Premium – FREE
Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q1 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
